Atsuko Ogino

2.1k citations

18 papers · 917 indexed · h-index 10

Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations 14
Oncology top 5%
- Lung Cancer Research Studies 6
- HER2/EGFR in Cancer Research 5
- Colorectal Cancer Treatments and Studies 2
Cancer Research top 10%
Pathology and Forensic Medicine top 10%
Molecular Biology
- Cancer therapeutics and mechanisms 5
- Retinoids in leukemia and cellular processes 2
- PI3K/AKT/mTOR signaling in cancer 2
Epidemiology
- Neuroendocrine Tumor Research Advances 2

Co-authors: Pasi A. Jänne Christine Lydon Katsuyuki Kiura Mitsune Tanimoto Mohit Butaney Lynette M. Sholl Nagio Takigawa Bruce E. Johnson
Cited by: Pulmonary and Respiratory Medicine Oncology Cancer Research
Journals: Cancer Research (4 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (1 paper)
Partner nations: Japan United States United Kingdom

In The Last Decade

Atsuko Ogino

17 papers receiving 897 citations

Peers

Countries citing papers authored by Atsuko Ogino

Since Specialization

Citations

This map shows the geographic impact of Atsuko Ogino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Ogino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Ogino more than expected).

Fields of papers citing papers by Atsuko Ogino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Ogino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Ogino. The network helps show where Atsuko Ogino may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Atsuko Ogino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Atsuko Ogino Line = papers co-authored together Atsuko Ogino links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations Molecular Oncology ·Atsuko Ogino,Jihyun Choi,Kuzmynchuk Nataliya V.,Margaret K. Wilkens,Antonio Calles,Man Xu,Anika E. Adeni,Emily S. Chambers,Marzia Capelletti,Mohit Butaney,Nathanael S. Gray,Prafulla C. Gokhale,Sangeetha Palakurthi,Paul T. Kirschmeier,Geoffrey R. Oxnard,Lynette M. Sholl,Pasi A. Jänne	2020	16
2	Ovarian abscess caused by Helicobacter cinaedi in a patient with endometriosis IDCases ·Hiroshi Satō,Atsuko Ogino,A. Burzynski,Dima Nourma Permata,Robeth Akbar,Sam Griffin,Sushil K. Satijia,E CUMSILLE,Mutmainnah Mutmainnah,Lisa Thompson-Caruthers,梁峥,T Goto,Masaya Hirose	2019	4
3	Abstract 1732: Switch to MET oncogene dependence as a novel mechanism of drug resistance in EGFR-mutant lung cancer Cancer Research ·Гульмира Жумагалиевна Ерланова,Raymond M. Paranal,Michael J. Poitras,Man Xu,Stephen Wang,Atsuko Ogino,Jihyun Choi,Fawaz Mohammed Almutair,Heidi M. Haikala,Jieun Son,Kuzmynchuk Nataliya V.,Masahiko Yanagita,Prafulla C. Gokhale,George Q. Daley,Pasi A. Jänne	2019	2
4	Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors Cancer Research ·Takayuki Kosaka,Junko Tanizaki,Raymond M. Paranal,Hideki Endoh,Christine Lydon,Marzia Capelletti,Claire E. Repellin,Jihyun Choi,Atsuko Ogino,Antonio Calles,Dalia Ercan,Amanda J. Redig,Magda Bahcall,Geoffrey R. Oxnard,Michael J. Eck,Pasi A. Jänne	2017	100
5	Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR -Mutant Lung Cancer Cancer Discovery ·里子木村,Chunxiao Xu,Sharmeen Uddin,Marzia Capelletti,Dalia Ercan,Atsuko Ogino,Christine A. Pratilas,Neal Rosen,Nathanael S. Gray,Kwok‐Kin Wong,Pasi A. Jänne	2015	159
6	Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non–Small Cell Lung Cancer Clinical Cancer Research ·Stephanie Cardarella,Atsuko Ogino,Mizuki Nishino,Mohit Butaney,Jeanne Shen,Christine Lydon,Beow Y. Yeap,Lynette M. Sholl,Bruce E. Johnson,Pasi A. Jänne	2013	274
7	The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor Lung Cancer ·Naruyuki Kobayashi,Shinichi Toyooka,Junichi Soh,Hiromasa Yamamoto,Hideaki Dote,Kensuke Kawasaki,Hiroki Otani,Takafumi Kubo,Masaru Jida,Tsuyoshi Ueno,Midori Ando,Atsuko Ogino,Katsuyuki Kiura,Shinichiro Miyoshi	2011	44
8	Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications Journal of Cancer Research and Clinical Oncology ·Yoshihiko Segawa,Guadalupe Diaz,Masanori Fujii,Isao Oze,Yoshiro Fujiwara,Yuka Kato,Atsuko Ogino,Eisaku Komori,Shigeki Sawada,Motohiro Yamashita,Rieko Nishimura,Norihiro Teramoto,Shigemitsu Takashima	2009	29
9	Effects of Vandetanib on Lung Adenocarcinoma Cells Harboring Epidermal Growth Factor Receptor T790M Mutation In vivo Cancer Research ·Eiki Ichihara,Kadoaki Ohashi,Nagio Takigawa,岡部和宏,Atsuko Ogino,Mitsune Tanimoto,Katsuyuki Kiura	2009	55
10	[Intrapleural chemotherapy--current status and problems in Japan]. PubMed ·Atsuko Ogino,Tetsu Shinkai	2008	0
11	The Effect of Gefitinib on B-RAF Mutant Non-small Cell Lung Cancer and Transfectants Journal of Thoracic Oncology ·Shinichi Toyooka,Akiko Uchida,Hisayuki Shigematsu,Junichi Soh,Atsuko Ogino,Minoru Takata,Katsuyuki Kiura,Mamoru Ouchida,Takayuki Kosaka,Motoi Aoe,Tetsuya Mitsudomi,Hiroshi Date	2007	2
12	Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib‐resistance in cells carrying EGFR mutation Cancer Science ·Akiko Uchida,Seiki Hirano,Hiroyuki Kitao,Atsuko Ogino,Petr Matěj,Shinichi Toyooka,Nagio Takigawa,Masahiro Tabata,Minoru Takata,Katsuyuki Kiura,Mitsune Tanimoto	2007	41
13	Emergence of Epidermal Growth Factor Receptor T790M Mutation during Chronic Exposure to Gefitinib in a Non–Small Cell Lung Cancer Cell Line Cancer Research ·Atsuko Ogino,Hiroyuki Kitao,Seiki Hirano,Akiko Uchida,Masamichi Ishiai,Toshiyuki Kozuki,Nagio Takigawa,Minoru Takata,Katsuyuki Kiura,Mitsune Tanimoto	2007	153
14	Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non‐small‐cell lung cancer: Experience at a single institution American Journal of Hematology ·Keitaro Matsuo,Katsuyuki Kiura,Masahiro Tabata,Akiko Uchida,Katsuyuki Hotta,Ni Nyoman Cipta Dewi,Shiro Kubonishi,Atsuko Ogino,Yoshiro Fujiwara,Hiromi Nakajima,Katsuji Shinagawa,Fumihiko Ishimaru,Hiroshi Ueoka,Mitsune Tanimoto	2006	7
15	Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group Experience Acta Oncologica ·Katsuyuki Hotta,Hiroshi Ueoka,Katsuyuki Kiura,Masahiro Tabata,Atsuko Ogino,Shigeki Umemura,Shingo Harita,Kenichi Gemba,Toshiro Yonei,Akihiro Bessho,Tadashi Maeda,Mitsune Tanimoto	2005	18
16	Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer. PubMed ·Katsuyuki Hotta,Nagio Takigawa,Katsuyuki Kiura,Masahiro Tabata,Shigeki Umemura,Atsuko Ogino,Akiko Uchida,Akihiro Bessho,Yoshihiko Segawa,Tetsu Shinkai,Naoyuki Nogami,Shingo Harita,Niro Okimoto,Hiroshi Ueoka,Mitsune Tanimoto	2005	7
17	Incidence of acute promyelocytic leukemia during gefitinib treatment for advanced non-small cell lung cancer Journal of Clinical Oncology ·Atsushi Uchida,Masahiro Tabata,Keitaro Matsuo,Atsuko Ogino,Yasuhiro Fujiwara,Katsuyuki Hotta,Katsuji Shinagawa,Katsuyuki Kiura,Hiroshi Ueoka,Mitsune Tanimoto	2005	1
18	Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer Journal of Clinical Oncology ·Katsuyuki Kiura,H. Gründei,Nagio Takigawa,Akihiro Bessho,Shingo Harita,Shigeki Umemura,Atsuko Ogino,Guolin Yuan,Hiroshi Ueoka,Mitsune Tanimoto	2005	5

About Atsuko Ogino

Atsuko Ogino is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 18 papers that have together received 917 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (6 papers), Cancer therapeutics and mechanisms (5 papers), HER2/EGFR in Cancer Research (5 papers), Neuroendocrine Tumor Research Advances (2 papers), Retinoids in leukemia and cellular processes (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (673 citations), Oncology (527 citations) and Cancer Research (176 citations). Atsuko Ogino has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Pasi A. Jänne, Christine Lydon, Katsuyuki Kiura, Mitsune Tanimoto, Mohit Butaney, Lynette M. Sholl, Nagio Takigawa, Bruce E. Johnson, Mizuki Nishino and Jeanne Shen. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Molecular Oncology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact